Adjust Font Size:

Press Releases

Advanced Cell Technology’s Chief Scientific Officer Michael West, Ph.D. to be Featured Guest Speaker at Rodman & Renshaw Techvest 7th Annual Healthcare Conference

Worcester, MA - Advanced Cell Technology, Inc.'s (OTC BB: ACTC) Chief Scientific Officer, Michael D. West, Ph.D. has accepted an invitation to present as a Featured Guest Speaker at Rodman & Renshaw Techvest 7th Annual Healthcare Conference at 1:30 PM EDT Monday, November 7th at the Palace Hotel in New York City. Dr. West, renowned expert in human embryonic stem cell research and regenerative medicine, will discuss trends in these fields.

Additionally, William M. Caldwell, Chief Executive Officer of Advanced Cell, and James G. Stewart, Senior VP & Chief Financial Officer, will provide a company overview at the Conference at 10:50 A.M. EDT Monday, November 7, describing Advanced Cell's continued efforts to develop technologies in the emerging area of regenerative medicine, including Advanced Cell's recent announcement of a breakthrough technique to generate embryonic stem cells that maintains the developmental potential of an embryo.

A live audio webcast of management's presentation can be accessed on the following website, "www.wsw.com/webcast/rrshq7/actc/":http://www.wsw.com/webcast/rrshq7/actc/. An audio replay of the presentation will also be available for 90 days after the conference. A downloadable presentation is also available from the conference presentations page of the company's website at "www.advancedcell.com/conference-presentations/":http://www.advancedcell.com/conference-presentations/.

About Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc. is a biotechnology company applying stem cell technology in the emerging field of regenerative medicine. The company is currently headquartered in Worcester, Massachusetts. For more information about the company visit "www.advancedcell.com":http://www.advancedcell.com

Forward-Looking Statements

Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and its subsidiary, Advanced Cell, Inc., and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended June 30, 2005.

Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.

Press Contact


John Nesbett, Amanda Watkins
(212) 825-3210

Download PDF


11.07.05.pdf

To view PDF Files, you must have Acrobat Reader.

Download Adobe Acrobat